throbber
THE CANCER DICTIONARY
`
`NOVARTIS EXHIBIT 2078
`Breckenridge v. Novartis, IPR 2017-01592
`Page 1 of 6
`
`

`

`THE CANCER DICTIONARY
`
`Roberta Altman
`Michael J. Sarg, M.D.
`Associate Chief of Medical Oncology,
`St. Vincent's Hospital, New York City
`
`Associate Professor of Clinical Medicine,
`New York Medical College
`
`e
`RlctsOnFtle
`
`AN INFOBASE HOLDINGS COMPANY
`
`NOVARTIS EXHIBIT 2078
`Breckenridge v. Novartis, IPR 2017-01592
`Page 2 of 6
`
`

`

`The Cancer Dictionary
`
`Copyright© 1992 by Roberta Altman and Michael]. Sarg, M.D.
`
`All rights reserved. No part of this book may be reproduced or utilized in any form
`or by any means, electronic or mechanical, including photocopying, recording, or
`by any information storage or retrieval systems, without permission in writing
`from the publisher. For information contact:
`Facts On File, Inc.
`460 Park Avenue South
`New York, NY 10016
`
`Library of Congress Cataloging-in-Publication Data
`
`Altman, Roberta
`The cancer dictionary / Roberta Altman, Michael Sarg.
`p.
`cm.
`Includes Bibliographical references and index.
`ISBN 0-8160-2608-4 (hdalk. paper)
`ISBN 0-8160-3027-8 (pb)
`1. Cancer- Dictionaries. I. Sarg, Michael. II. Title.
`[DNLM: 1. Neoplasms- dictionaries. QZ 13 A468c]
`RC262.A39 1992
`616.99'4'003- dc20
`DNLM/DLC
`for Library of Congress
`
`91-46941
`
`Facts On File books are available at special discounts when purchased in bulk
`quantities for businesses, associations, institutions, or sales promotions.
`Please contact our Special Sales Department in New York at 212/683-2244
`or 800/322-8755.
`Text design by Ron Monteleone
`Jacket design by Mary McKenna-Ridge
`Composition by the Maple-Vail Book Manufacturing Group
`Manufactured by Hamilton Printing Company
`Printed in the United States of America
`
`10 9 8 7 6 5 4 3
`This book is printed on acid-free paper.
`
`NOVARTIS EXHIBIT 2078
`Breckenridge v. Novartis, IPR 2017-01592
`Page 3 of 6
`
`

`

`28
`
`biotechnology
`
`Female~~~
`
`Male ~ ~
`( ~ v r--- ~
`
`Ureter--+----,
`
`11------- ureter
`
`1-------Bladder
`
`Bladder--+---(cid:173)
`
`cv1-------'t- Prostate
`
`The female and male urinary systems. Courtesy NCI.
`
`biotechnology the use of living organisms or their
`products to make or modify a substance. It includes
`genetic engineering and HYBRIDOMA TECHNOLOGY. This
`area of research, investigation, and production ex(cid:173)
`panded greatly during the 1980s and continues to
`do so.
`
`bis (chloromethyl ether) see CARCINOGENS.
`
`bladder cancer the presence of malignant (cancer(cid:173)
`ous) cells in the bladder. Although not seen that often
`in the United States as compared with other coun(cid:173)
`tries, it is the more frequent cancer of the urinary
`tract. In 1992 about 51,600 people were diagnosed
`with bladder cancer in the United States, and about
`9,500 died from the disease. Bladder cancer occurs
`most frequently in white adults between the ages of
`50 and 70, with men developing it about three times
`more often than women .
`The most common type of bladder cancer is tran(cid:173)
`sitional cell carcinoma (90%), which arises from the
`transitional epithelial cells that line the bladder. The
`other types of bladder cancer include papillary, squa(cid:173)
`mous cell carcinoma, and adenocarcinoma.
`Scientists believe that bladder cancer develops over
`many years as a gradual change in bladder cells. The
`precise cause of bladder cancer is still not known.
`
`However, several risk factors have been identified. It
`is estimated that smoking is a contributing factor in
`as many as half the bladder cancers in men and a
`third of the bladder cancers in women. Smokers have
`a two to three times greater risk of developing bladder
`cancer. Exposure of workers in the dye industries is
`thought to be a contributing factor in bladder cancer.
`Other occupations that have been linked to an in(cid:173)
`creased risk of bladder cancers include those in the
`rubber, leather, textile, and chemical industries, as
`well as hairdressers, machinists, metalworkers , paint(cid:173)
`ers, printers, and truck drivers. A bladder infection
`caused by the parasitic flatworm Schistosoma hae(cid:173)
`matobium increases the risk of squamous cell bladder
`cancer. Other urinary infections may also increase
`the risk.
`Some medical treatments may present a risk as
`well. The Food and Drug Administration has banned
`the use of phenacetin, which has been associated
`with bladder cancer, in painkillers. The risk of blad(cid:173)
`der cancer increases as a result of treatment with the
`anticancer drug cyclophosphamide. Some studies have
`shown an association between radiation therapy to
`the pelvis and bladder cancer.
`The most common symptom of bladder cancer is
`blood in the urine, usually associated with increased
`frequency of urination. (This can be a symptom for
`
`NOVARTIS EXHIBIT 2078
`Breckenridge v. Novartis, IPR 2017-01592
`Page 4 of 6
`
`

`

`:re expected to take part in the
`trial.
`.
`ss toxic than most anucancer
`lous side effects, and it is gen(cid:173)
`Because it has only been avail-
`effects are not known.
`~-term
`:ts have not been seen in women
`' tamoxifen for ten years. Doc(cid:173)
`~at tamoxifen can be taken in-
`
`dies show additional advantages
`A study completed in 1990
`nt.
`11 . k
`ifen may reduce the overa ns
`; much as 40%. Data from other
`. tamoxifen may prevent bone
`.
`the risk of osteoporosis (a
`ng
`.
`)
`mt and strength of bone ussue .
`<ifen in the treatment of other
`Jrostate, skin (melanoma), and
`. b .
`explored Its use as a
`so emg

`g is also being examined.
`en by mouth twice a day. For
`are no side effects. Some of the
`l·f uncommon, include
`1y occur,
`.
`d
`lashes, subtle weight gam, an
`ry uncommon side effects may
`E MARROW DEPRESSION, vagmal
`menstrual irregularity, bone
`irge,
`l' ht
`skin rashes, depression,
`l~ •
`·adaches. Tamoxifen is a very im(cid:173)
`. drug in the treatment of breast
`
`l. hts are
`Place where ultraviolet ig
`h many tan-
`artificial tan. Althoug
`d
`i-
`it pre orn
`ave sunlamps t at em
`h
`k·n
`.
`'d ed as I
`on they are still cons1 er
`. d d
`,
`.
`l
`cons1 ere
`radiation 1s no onger f h more
`And the small amount o t _e rnit·

`d'

`that 1s e
`,urning UVB ra iauon
`. k As
`;nificant increase m ca had taken

`ncer ns ·
`:ral Trade Comm1ss10n d rnanufac·
`ee major importers an
`·ng the

`resent!
`, devices for m1srep
`ducts.
`
`--------------------------------~269
`T cell lymphoma see MYCos1s FUNGOIDEs.
`
`TAX see TAXOL.
`
`Teslac
`
`taxol (tax' ol) [TAX] an anticancer drug under in(cid:173)
`vestigation for its use in the treatment of ovarian and
`other cancers. While it has shown great promise,
`obtaining it in quantities sufficient to treat all the
`patients who might benefit from it is a problem.
`Taxol is derived from the bark of the slow-growing
`Pacific yew tree located in the rapidly dwindling
`ancient forests of the Pacific Northwest. The bark
`from as many as 4,000 trees may be used to produce
`one kilogram of taxol. Since it takes about 20 years
`for the yew trees to grow shoulder high, the devel(cid:173)
`opment of a synthetic taxol is being investigated.
`Taxol is undergoing CLINICAL TRIALS based on the
`expectation that eventually it will be available in a
`quantity sufficient to meet the demand.
`TBI (total body irradiation) see WHOLE BODY RA(cid:173)
`DIATION.
`
`TC a combination of the anticancer drugs 6-TG and
`ARA-C sometimes used in the maintenance therapy of
`ALL See individual drug listings for side effects. See
`also COMBINATION CHEMOTHERAPY.
`
`TCC see TRANSITIONAL CELL CANCER OF THE RENAL
`PELVIS AND URETER.
`
`T cell [T lymphocytes] one of the two major types
`of lymphocytes, which are white blood cells. (The
`other major type is the B CELL) T cells are processed
`in the thymus and are part of the body's IMMUNE
`SYSTEM. Regulatory T cells play a major role in or(cid:173)
`chestrating the very complex immune system. The
`most important T cells are the "helper/inducer" cells
`(identified by the T4 marker), which activate B cells,
`other T cells, NATURAL KILLER CELLS, and MACRO(cid:173)
`PHAGES. Another regulatory T cell (identified by the
`TB marker) turns off or suppresses those same cells.
`The killer cytotoxic T cells (also identified by the T8
`marker) rid the body of cells that are perceived as
`harmful-cells infected by a virus or transformed by
`cancer-and reject foreign substances such as tissue
`and organ grafts as well. See WHITE BLOOD CELLS.
`l cell leukemia a type of acute lymphocytic leuke(cid:173)
`r1a (ALL) affecting immature STEM CELLS. It accounts
`0~~ about 12% of ALL cases. It occurs primarily in
`er adolescents and young adults.
`
`technesium (tek-ne'ze-um) a radioactive substance
`that may be used in some NUCLEAR SCANS.
`
`tegafur [Florafur, 5-fluoro-1-tetrahydro-2-furyl -ur(cid:173)
`acil] an anticancer drug being investigated for its
`use in the treatment of breast, stomach, esophagus,
`colon/rectal, and genitourinary tract cancers. It is
`administered by IV (injected into a vein) or taken by
`mouth. Common side effects may include nausea,
`vomiting, flushing, dizziness, and apprehension with
`rapid administration. Occasional or rare side effects
`may include mouth sores, loss of muscle coordina(cid:173)
`tion, diarrhea, lethargy, and confusion.
`
`teletherapy see EXTERNAL RADIATION THERAPY.
`
`10-EDAM see EDATREXATE.
`
`teniposide [VM-26] an anticancer drug being in(cid:173)
`vestigated for its use in the treatment of LYMPHOMA,
`LEUKEMIA, MELANOMA, and cancers of the brain, blad(cid:173)
`der, lung, ovary, breast, and kidney. It is administered
`by IV (injected into a vein). BONE MARROW DEPRESSION
`may be a side effect. Other, less common side effects
`may include nausea, vomiting, hair loss, fever, liver
`problems, and loss of reflexes.
`
`TENS see TRANSCUTANEOUS ELECTRICAL NERVE STIM(cid:173)
`
`ULATION.
`
`tension relaxation see RELAXATION TECHNIQUES.
`
`teratoma a neoplasm (abnormal growth of tissue)
`composed of a number of different types of tissue.
`One type of TESTICULAR CANCER is called teratoma, as
`is one type of congenital BRAIN CANCER.
`
`terminal in cancer, a term used to characterize a
`patient with progressive advanced disease with vital
`organ involvement who has a very limited life expec(cid:173)
`tancy in the absence of any useful further therapy.
`Duration of life has been defined in various ways,
`but most understand "terminal" to be six months or
`less left to live.
`
`Teslac [testolactone) see ANDROGEN.
`
`NOVARTIS EXHIBIT 2078
`Breckenridge v. Novartis, IPR 2017-01592
`Page 5 of 6
`
`NOVARTIS EXHIBIT 2078
`Breckenridge v. Novartis, IPR 2017-01592
`Page 5 of 6
`
`

`

`(NCI) stages urethral cancer by location and whether
`it has spread:
`
`• Anterior-cancer in the part of the urethra that is
`closest to the outside of the body; these tumors are
`likely to be noninvasive
`• Posterior-cancer in the part of the urethra that
`connects to the bladder; this tumor is more likely
`to invade nearby tissue
`, Urethral cancer associated with invasive bladder
`cancer-the patient also has bladder cancer
`• Recurrent-cancer has returned to the same site or
`to another part of the body after treatment.
`
`Treatment depends on the stage of the disease and
`other factors. Surgical treatments that may be used
`include FU LGURATION , LASER THERAPY, CYSTOURE(cid:173)
`THRECTOMY, PENECTOMY (in men), CYSTOPROSTATEC(cid:173)
`TOMY (in men), or ANTERIOR EXENTERATION (in women).
`For specific information on the latest state-of-the-art
`treatment, by stage, call NCI's Cancer Information
`Service at 1-800-4-CANCER.
`
`urethrogram (u-re'thro-gram) see URETHROGRAPHY.
`
`urethrography (u-re"throg' rah-fe) examination of
`the urethra by x RAY for the presence of a tumor or
`suspicious area. This procedure may be used in the
`diagnosis of cancer in the urethra of men.
`
`urinalysis (u"rT-nal'i-sis) [urine analysis (UA)] ex(cid:173)
`amination of urine. It may be performed in the
`diagnosis of kidney cancer and many other disorders.
`The degree of concentration of the urine compared
`with plain water is called specific gravity (SG) and
`can be an indication of a urinary obstruction. The
`amount of acidity, protein, sugar, and ketones (or(cid:173)
`ganic compounds) in the urine can indicate acidosis
`or alkalosis, kidney damage, diabetes, and other dis(cid:173)
`orders. A urine sediment exam checks for red cells,
`white cells, kidney cells, crystals, and microorga(cid:173)
`nisms. It may be used in the diagnosis of urinary
`tract cancers, especially bladder cancer, as well as
`kidney damage, urinary tract infection, or gout.
`
`urinary diversion creation of a new way to eliminate
`urine when the bladder and/or urethra has been
`removed. The standard procedure used to be forma(cid:173)
`tion of a STOMA, or surgical opening through which
`urine passed. The urine would be emptied into a flat
`bag located outside the body. Newer forms of urinary
`
`uterine sarcoma
`
`285
`
`diversion have made an external urinary device un(cid:173)
`necessary in many cases. Surgeons try to use the
`newer techniques whenever possible. See CONTINENT
`!LEAL RESERVOIR, BRICKER'S POUCH, CAMEY PROCEDURE,
`!LEAL BLADDER, and URETEROSIGMOIDOSTOMY.
`
`urinary tract cancer cancer occurring in any of the
`tract (kidneys, bladder,
`the urinary
`in
`organs
`urethra) . See KIDN EY CANCER, BLADDER CANCER,
`URETERAL CANCER, URETHRAL CANCER, and PROSTATE
`CANCER.
`
`urine sediment test see URINALYSIS.
`
`urogram see UROGRAPHY.
`
`urography (u -rog'rah-fe) an x RAY examination of
`the kidneys, bladder, ureters, and urethra. This may
`be performed in patients who cannot tolerate an IVP.
`It may be used in the diagnosis of urinary tract
`cancers as well as other disorders.
`
`urologist (u-rol' o-jist) a medical doctor who spe(cid:173)
`cializes in diseases that affect the kidneys, ureters,
`urethra, bladder, prostate gland, and male sex organs.
`A urologist is an expert in diagnosis and in surgical
`treatment in the urologic area. A board-certified urol(cid:173)
`ogist has two years of postmedical training, three
`years of training in urologic surgery, and 18 months
`of independent practice. In addition, he or she
`has passed the written and oral exams given by the
`board.
`
`urostomy see OSTOMY.
`
`urticaria (ur"ti-ka 're-ah) [hives] an allergic reaction
`marked by itching welts. This may be a side effect of
`CHEMOTHERAPY. They may appear at the site of a
`chemotherapy (anticancer drug) injection or on other
`parts of the body. The hives may develop along the
`vein through which the chemotherapy was adminis(cid:173)
`tered as well as other locations. The hives usually
`disappear within several hours.
`
`us see ULTRASOUND.
`
`uterine sarcoma (u'ter-Tne sar-ko'mah) an ex(cid:173)
`tremely rare type of ENDOMETRIAL CANCER. It accounts
`for between 1 and 5% of all endometrial (uterine)
`
`NOVARTIS EXHIBIT 2078
`Breckenridge v. Novartis, IPR 2017-01592
`Page 6 of 6
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket